| Title | European Journal of Pharmaceutics and Biopharmaceutics |
| Abbreviation | Eur. J. Pharm. Biopharm. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmaceutical Science (Q1); Biotechnology (Q2); Medicine (miscellaneous) (Q2) |
| h-index | 185 |
| Overall Rank/Ranking | 5830 |
| SCImago Journal Rank (SJR) | 0.835 |
| Impact Score | 4.76 |
| Publisher | Elsevier B.V. |
| Country | Netherlands |
| ISSN | 18733441, 09396411 |
| Best Quartile | Q1 |
| Coverage History | 1991-2023 |
European Journal of Pharmaceutics and Biopharmaceutics is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q1); Biotechnology (Q2); Medicine (miscellaneous) (Q2). It is published by Elsevier B.V.. The overall rank of European Journal of Pharmaceutics and Biopharmaceutics is 5830. According to SCImago Journal Rank (SJR), this journal is ranked 0.835. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 185. The best quartile for this journal is Q1.
The ISSN of European Journal of Pharmaceutics and Biopharmaceutics journal is 18733441, 09396411. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. European Journal of Pharmaceutics and Biopharmaceutics is cited by a total of 3685 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of European Journal of Pharmaceutics and Biopharmaceutics is 4.76, which is computed in 2024 as per its definition. European Journal of Pharmaceutics and Biopharmaceutics IF is decreased by a factor of 0.37 and approximate percentage change is -7.21% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of European Journal of Pharmaceutics and Biopharmaceutics is 4.76. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.76 |
| 2022 | 5.13 |
| 2021 | 5.51 |
| 2020 | 5.52 |
| 2019 | 4.80 |
| 2018 | 5.05 |
| 2017 | 4.83 |
| 2016 | 4.61 |
| 2015 | 4.56 |
| 2014 | 4.28 |
European Journal of Pharmaceutics and Biopharmaceutics has an h-index of 185. It means 185 articles of this journal have more than 185 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of European Journal of Pharmaceutics and Biopharmaceutics is 18733441, 09396411. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of European Journal of Pharmaceutics and Biopharmaceutics is 5830. According to SCImago Journal Rank (SJR), this journal is ranked 0.835. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.835 |
| 2022 | 0.830 |
| 2021 | 0.857 |
| 2020 | 1.103 |
| 2019 | 1.059 |
| 2018 | 1.326 |
| 2017 | 1.342 |
| 2016 | 1.411 |
| 2015 | 1.437 |
| 2014 | 1.481 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 5830 |
| 2022 | 5663 |
| 2021 | 5179 |
| 2020 | 3771 |
| 2019 | 3943 |
| 2018 | 2793 |
| 2017 | 2780 |
| 2016 | 2623 |
| 2015 | 2580 |
| 2014 | 2355 |
European Journal of Pharmaceutics and Biopharmaceutics is published by Elsevier B.V.. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 1991-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of European Journal of Pharmaceutics and Biopharmaceutics is Eur. J. Pharm. Biopharm.. This abbreviation ('Eur. J. Pharm. Biopharm.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmaceutical Science (Q1); Biotechnology (Q2); Medicine (miscellaneous) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
European Journal of Pharmaceutics and Biopharmaceutics latest impact IF is 4.76. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 5.52 (2020) and 4.28 (2014), respectively, in the last 10 years. Moreover, its average IS is 4.91 in the previous 10 years.
The European Journal of Pharmaceutics and Biopharmaceutics has an SJR (SCImago Journal Rank) of 0.835, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.481 in 2014 and the lowest being 0.830 in 2022. Furthermore, the average SJR of the European Journal of Pharmaceutics and Biopharmaceutics over the previous 10-year period stands at 4.91.
The latest h-index of the European Journal of Pharmaceutics and Biopharmaceutics is 185.
The European Journal of Pharmaceutics and Biopharmaceutics is published by the Elsevier B.V., with its country of publication being the Netherlands.
The European Journal of Pharmaceutics and Biopharmaceutics is currently ranked 5830 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2355 in 2014 and its lowest position of 5830 in 2023.
The standard ISO4 abbreviation for the European Journal of Pharmaceutics and Biopharmaceutics is Eur. J. Pharm. Biopharm..
European Journal of Pharmaceutics and Biopharmaceutics is classified as a journal that the Elsevier B.V. publishes.
The European Journal of Pharmaceutics and Biopharmaceutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The European Journal of Pharmaceutics and Biopharmaceutics is assigned the following International Standard Serial Numbers (ISSN): 18733441, 09396411.
The best quartile for the European Journal of Pharmaceutics and Biopharmaceutics is Q1 (2023).
The European Journal of Pharmaceutics and Biopharmaceutics coverage history can be summarized as follows: 1991-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| International Journal of Applied Linguistics | journal | 6241 | Wiley-Blackwell Publishing Ltd | 53 | 1.91 |
| Modern Language Journal | journal | 1100 | Wiley-Blackwell | 112 | 3.93 |
| British Journal of Special Education | journal | 16076 | Wiley-Blackwell Publishing Ltd | 44 | 0.78 |
| Syntax | journal | 3731 | Wiley-Blackwell Publishing Ltd | 33 | 0.93 |
| International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS | conference and proceedings | 678 | Association for Computing Machinery (ACM) | 106 | 7.58 |
| Museum Management and Curatorship | journal | 10406 | Routledge | 40 | 1.72 |
| Archiv fur Geflugelkunde | journal | 28770 | Verlag Eugen Ulmer | 30 | 0.00 |
| Proceedings of the Royal Society of Queensland | journal | 21886 | Royal Society of Queensland | 12 | 0.00 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 | |
| Society and Economy | journal | 17871 | Akademiai Kiado | 16 | 0.87 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.76 |
| 2022 | 5.13 |
| 2021 | 5.51 |
| 2020 | 5.52 |
| 2019 | 4.80 |
| 2018 | 5.05 |
| 2017 | 4.83 |
| 2016 | 4.61 |
| 2015 | 4.56 |
| 2014 | 4.28 |
